Sitemap
- Welcome!
- Program Overview
- Program Objectives
- Current Trainees
- Application
- Frequently Asked Questions
- Training in Clinical and Translational Research
- Who We Are
- Testimonials: From Fellow to Faculty
- Contact
- Learn More about Vanderbilt’s Master of Science in Clinical Investigation
- Sitemap
- Leadership Team
- “The MSCI program helped me establish a strong foundation in study design, biostatistics, research ethics, clinical trial management and regulatory issues, and how to successfully apply and get grants.” Ingrid Mayer, MD, MSCI ’16
- Maya Yiadom, MD, MPH, MSCI ’18 leads lecture on pragmatic trials in MSCI 5044 Clinical Trials course.
- Jon Casey, MD, MSCI ’19
- Kalpana Manthiram, MD, MSCI ’15 NIH Clinical Fellow, National Human Genome Research Institute, with her mentor Kathryn Edwards, MD and mentoring committee
- Class of 2017-2019
- Donald Lynch, MD, MSCI ’21
- Satya Das, MD, MSCI ’20, national principal investigator for clinical trial testing ATR inhibitor in difficult-to-treat cancers
Alphabetical
- “The MSCI program helped me establish a strong foundation in study design, biostatistics, research ethics, clinical trial management and regulatory issues, and how to successfully apply and get grants.” Ingrid Mayer, MD, MSCI ’16
- Application
- Calendar of Events
- Class of 2017-2019
- Class of 2021 – 2023
- Class of 2022 – 2024
- Class of 2023 – 2025
- Contact
- Current Trainees
- Donald Lynch, MD, MSCI ’21
- Founders
- Frequently Asked Questions
- Jon Casey, MD, MSCI ’19
- Kalpana Manthiram, MD, MSCI ’15 NIH Clinical Fellow, National Human Genome Research Institute, with her mentor Kathryn Edwards, MD and mentoring committee
- Leadership Team
- Learn More about Vanderbilt’s Master of Science in Clinical Investigation
- Maya Yiadom, MD, MPH, MSCI ’18 leads lecture on pragmatic trials in MSCI 5044 Clinical Trials course.
- MD/MSCI Dual Degree
- MSCI Course Directors & Courses
- MSCI Course Schedule
- MSCI Course Schedule, 2023-2024
- MSCI Outcomes
- Program Objectives
- Program Overview
- Publications
- Resources for Funding, Research, Grant Assistance, and Work/Life
- Satya Das, MD, MSCI ’20, national principal investigator for clinical trial testing ATR inhibitor in difficult-to-treat cancers
- Sitemap
- TENTATIVE MSCI Course Schedule, 2024-2025
- Testimonials: From Fellow to Faculty
- Training in Clinical and Translational Research
- Welcome!
- Who We Are